Skip to main navigation Skip to search Skip to main content

Pomalidomide alone or in combination with low-dose dexamethasone in relapsed and refractory multiple myeloma: A randomized phase 2 study

  • Paul G. Richardson
  • , David S. Siegel
  • , Ravi Vij
  • , Craig C. Hofmeister
  • , Rachid Baz
  • , Sundar Jagannath
  • , Christine Chen
  • , Sagar Lonial
  • , Andrzej Jakubowiak
  • , Nizar Bahlis
  • , Kevin Song
  • , Andrew Belch
  • , Noopur Raje
  • , Chaim Shustik
  • , Suzanne Lentzsch
  • , Martha Lacy
  • , Joseph Mikhael
  • , Jeffrey Matous
  • , David Vesole
  • , Min Chen
  • Mohamed H. Zaki, Christian Jacques, Zhinuan Yu, Kenneth C. Anderson

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Pomalidomide alone or in combination with low-dose dexamethasone in relapsed and refractory multiple myeloma: A randomized phase 2 study'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science